In addition to affecting the activity of ANS, sleep also exerts a significant regulatory effect on glycemic control by influencing the balance and levels of hormones including leptin, growth hormone-releasing peptide, insulin and cortisol (Balbo et al., 2010), which enhances the association between HRV metrics during sleep and glycemic control of T2DM patients. This evidence concerns the gene LEP and type 2 diabetes mellitus.